Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 124249 ointment for mild to moderate inverse psoriasis
2015-002098-40Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in inverse psoriasis comparing LEO 124249 ointment 30 mg/g with Vehicle ointment (2 arms). Primary endpoint: Total sign score at Week 6. Started Dec 2015; status: completed.
02
Drugs
delgocitinib
03
Conditions
inverse psoriasis
Beyond the preview
Go deeper on 2015-002098-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002098-40.